272 related articles for article (PubMed ID: 19363621)
21. Targeted therapy in gastric cancer.
Thiel A; Ristimäki A
APMIS; 2015 May; 123(5):365-72. PubMed ID: 25706252
[TBL] [Abstract][Full Text] [Related]
22. Metastatic gastric cancer treatment: a little slow but worthy progress.
Kanat O; O'Neil BH
Med Oncol; 2013 Mar; 30(1):464. PubMed ID: 23335104
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the antitumor effects and mechanisms of PF00299804, a pan-HER inhibitor, alone or in combination with chemotherapy or targeted agents in gastric cancer.
Nam HJ; Ching KA; Kan J; Kim HP; Han SW; Im SA; Kim TY; Christensen JG; Oh DY; Bang YJ
Mol Cancer Ther; 2012 Feb; 11(2):439-51. PubMed ID: 22135232
[TBL] [Abstract][Full Text] [Related]
24. Novel investigational drugs for gastric cancer.
Vecchione L; Orditura M; Ciardiello F; De Vita F
Expert Opin Investig Drugs; 2009 Jul; 18(7):945-55. PubMed ID: 19466878
[TBL] [Abstract][Full Text] [Related]
25. The role of epidermal growth factor receptor in prognosis and treatment of gastric cancer.
Hong L; Han Y; Brain L
Expert Rev Gastroenterol Hepatol; 2014 Jan; 8(1):111-7. PubMed ID: 24410474
[TBL] [Abstract][Full Text] [Related]
26. Recent advances and future trends in the targeted therapy of metastatic gastric cancer.
Al-Batran SE; Werner D
Expert Rev Gastroenterol Hepatol; 2014 Jul; 8(5):555-69. PubMed ID: 24665840
[TBL] [Abstract][Full Text] [Related]
27. Targeted therapy in advanced gastric carcinoma: the future is beginning.
Schinzari G; Cassano A; Orlandi A; Basso M; Barone C
Curr Med Chem; 2014; 21(8):1026-38. PubMed ID: 24304282
[TBL] [Abstract][Full Text] [Related]
28. Novel targets in gastric and esophageal cancer.
Valverde CM; Macarulla T; Casado E; Ramos FJ; Martinelli E; Tabernero J
Crit Rev Oncol Hematol; 2006 Aug; 59(2):128-38. PubMed ID: 16829119
[TBL] [Abstract][Full Text] [Related]
29. Molecular targets and biological modifiers in gastric cancer.
Carneiro F; Oliveira C; Leite M; Seruca R
Semin Diagn Pathol; 2008 Nov; 25(4):274-87. PubMed ID: 19013893
[TBL] [Abstract][Full Text] [Related]
30. New advances in targeted gastric cancer treatment.
Lazăr DC; Tăban S; Cornianu M; Faur A; Goldiş A
World J Gastroenterol; 2016 Aug; 22(30):6776-99. PubMed ID: 27570417
[TBL] [Abstract][Full Text] [Related]
31. Targeted therapies in the treatment of gastric cancer.
Ngeow J; Tan IB; Choo SP
Asia Pac J Clin Oncol; 2011 Sep; 7(3):224-35. PubMed ID: 21884434
[TBL] [Abstract][Full Text] [Related]
32. Targeted therapy for gastric cancer: Current status and future directions (Review).
Yuan DD; Zhu ZX; Zhang X; Liu J
Oncol Rep; 2016 Mar; 35(3):1245-54. PubMed ID: 26718131
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of different molecular targeted agents based on chemotherapy for gastric cancer patients treatment: a network meta-analysis.
Ren Z; Sun J; Sun X; Hou H; Li K; Ge Q
Oncotarget; 2017 Jul; 8(29):48253-48262. PubMed ID: 28477027
[TBL] [Abstract][Full Text] [Related]
34. Danusertib, a potent pan-Aurora kinase and ABL kinase inhibitor, induces cell cycle arrest and programmed cell death and inhibits epithelial to mesenchymal transition involving the PI3K/Akt/mTOR-mediated signaling pathway in human gastric cancer AGS and NCI-N78 cells.
Yuan CX; Zhou ZW; Yang YX; He ZX; Zhang X; Wang D; Yang T; Pan SY; Chen XW; Zhou SF
Drug Des Devel Ther; 2015; 9():1293-318. PubMed ID: 25767376
[TBL] [Abstract][Full Text] [Related]
35. Targeted therapy for advanced esophagogastric adenocarcinoma.
Kordes S; Cats A; Meijer SL; van Laarhoven HW
Crit Rev Oncol Hematol; 2014 Apr; 90(1):68-76. PubMed ID: 24183912
[TBL] [Abstract][Full Text] [Related]
36. Histone Deacetylase Inhibitor Trichostatin A Suppresses Cell Proliferation and Induces Apoptosis by Regulating the PI3K/AKT Signalling Pathway in Gastric Cancer Cells.
An X; Wei Z; Ran B; Tian H; Gu H; Liu Y; Cui H; Zhu S
Anticancer Agents Med Chem; 2020; 20(17):2114-2124. PubMed ID: 32593284
[TBL] [Abstract][Full Text] [Related]
37. c-Met targeting in advanced gastric cancer: An open challenge.
Marano L; Chiari R; Fabozzi A; De Vita F; Boccardi V; Roviello G; Petrioli R; Marrelli D; Roviello F; Patriti A
Cancer Lett; 2015 Aug; 365(1):30-6. PubMed ID: 26049023
[TBL] [Abstract][Full Text] [Related]
38. Update on Biomarkers in Development of Anti-angiogenic Drugs in Gastric Cancer.
Jia S; Cai J
Anticancer Res; 2016 Mar; 36(3):1111-8. PubMed ID: 26977006
[TBL] [Abstract][Full Text] [Related]
39. Gastric Cancer: New Drugs - New Strategies.
Schulte N; Ebert MP; Härtel N
Gastrointest Tumors; 2014 May; 1(4):180-94. PubMed ID: 26674336
[TBL] [Abstract][Full Text] [Related]
40. Identifying and targeting cancer stem cells in the treatment of gastric cancer.
Bekaii-Saab T; El-Rayes B
Cancer; 2017 Apr; 123(8):1303-1312. PubMed ID: 28117883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]